Martin H Sørensen1,2, Annemie S Bojer3,2, Julie R N Pontoppidan3, David A Broadbent4,5, Sven Plein5, Per L Madsen6,7, Peter Gæde3,2. 1. Department of Cardiology and Endocrinology, Slagelse Hospital, Region Zealand, Denmark mahso@regionsjaelland.dk. 2. Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. 3. Department of Cardiology and Endocrinology, Slagelse Hospital, Region Zealand, Denmark. 4. Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds, U.K. 5. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K. 6. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Capital Region of Denmark, Denmark. 7. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Abstract
OBJECTIVE: To examine differences in myocardial blood flow (MBF) at rest and during stress between patients with type 2 diabetes and control subjects, and to identify potential predictors of changes in MBF at rest and during stress. RESEARCH DESIGN AND METHODS: A cross-sectional study was conducted of 193 patients with type 2 diabetes and 20 age- and sex-matched control subjects. Cardiovascular magnetic resonance was used to evaluate left ventricular structure and function and MBF at rest and during adenosine-induced stress. MBF was derived as the mean of the flow within all segments of a midventricular slice. RESULTS: Patients with type 2 diabetes had higher global MBF at rest (0.81 ± 0.19 mL/min/g) and lower global MBF during stress (2.4 ± 0.9 mL/min/g) than control subjects (0.61 ± 0.11 at rest, 3.2 ± 0.8 mL/min/g under stress; both P < 0.01). Patients with macroalbuminuria had lower MBF during stress (1.6 ± 0.5 mL/min/g) than did patients with microalbuminuria (2.1 ± 0.7 mL/min/g; P = 0.04), who in turn had lower MBF during stress than did normoalbuminuric patients (2.7 ± 0.9 mL/min/g; P < 0.01). Patients with severe retinopathy had lower MBF during stress (1.8 ± 0.6 mL/min/g) than patients with simplex retinopathy (2.3 ± 0.7 mL/min/g; P < 0.05) and those who did not have retinopathy (2.6 ± 1.0 mL/min/g; P < 0.05). Albuminuria and retinopathy were associated with reduced MBF during stress in a multiple regression analysis. Stress-related MBF inversely correlated with myocardial extracellular volume (P < 0.001; R 2 = 0.37), a measure of diffuse myocardial fibrosis. A trend toward lower basal MBF was observed in patients treated with sodium-glucose cotransporter 2 inhibitors (P = 0.07). CONCLUSIONS: Patients with type 2 diabetes have higher global MBF at rest and lower maximal MBF during vasodilator-induced stress than control subjects. Reduced MBF during stress is associated with diabetes complications (albuminuria and retinopathy) and is inversely correlated with diffuse myocardial fibrosis.
OBJECTIVE: To examine differences in myocardial blood flow (MBF) at rest and during stress between patients with type 2 diabetes and control subjects, and to identify potential predictors of changes in MBF at rest and during stress. RESEARCH DESIGN AND METHODS: A cross-sectional study was conducted of 193 patients with type 2 diabetes and 20 age- and sex-matched control subjects. Cardiovascular magnetic resonance was used to evaluate left ventricular structure and function and MBF at rest and during adenosine-induced stress. MBF was derived as the mean of the flow within all segments of a midventricular slice. RESULTS:Patients with type 2 diabetes had higher global MBF at rest (0.81 ± 0.19 mL/min/g) and lower global MBF during stress (2.4 ± 0.9 mL/min/g) than control subjects (0.61 ± 0.11 at rest, 3.2 ± 0.8 mL/min/g under stress; both P < 0.01). Patients with macroalbuminuria had lower MBF during stress (1.6 ± 0.5 mL/min/g) than did patients with microalbuminuria (2.1 ± 0.7 mL/min/g; P = 0.04), who in turn had lower MBF during stress than did normoalbuminuric patients (2.7 ± 0.9 mL/min/g; P < 0.01). Patients with severe retinopathy had lower MBF during stress (1.8 ± 0.6 mL/min/g) than patients with simplex retinopathy (2.3 ± 0.7 mL/min/g; P < 0.05) and those who did not have retinopathy (2.6 ± 1.0 mL/min/g; P < 0.05). Albuminuria and retinopathy were associated with reduced MBF during stress in a multiple regression analysis. Stress-related MBF inversely correlated with myocardial extracellular volume (P < 0.001; R 2 = 0.37), a measure of diffuse myocardial fibrosis. A trend toward lower basal MBF was observed in patients treated with sodium-glucose cotransporter 2 inhibitors (P = 0.07). CONCLUSIONS:Patients with type 2 diabetes have higher global MBF at rest and lower maximal MBF during vasodilator-induced stress than control subjects. Reduced MBF during stress is associated with diabetes complications (albuminuria and retinopathy) and is inversely correlated with diffuse myocardial fibrosis.
Authors: William B Horton; Linda A Jahn; Lee M Hartline; Kevin W Aylor; James T Patrie; Eugene J Barrett Journal: J Physiol Date: 2021-02-02 Impact factor: 5.182
Authors: Ida K B Rasmussen; Philip Hasbak; Bernt J von Scholten; Jens C Laursen; Emilie H Zobel; Lars Jorge Diaz; Lene Holmvang; Rasmus S Ripa; Peter Rossing; Andreas Kjaer; Tine W Hansen Journal: Diabet Med Date: 2021-01-25 Impact factor: 4.359
Authors: Amrit Chowdhary; Sharmaine Thirunavukarasu; Nicholas Jex; Lauren Coles; Charles Bowers; Anshuman Sengupta; Peter Swoboda; Klaus Witte; Richard Cubbon; Hui Xue; Peter Kellman; John Greenwood; Sven Plein; Eylem Levelt Journal: Obesity (Silver Spring) Date: 2022-03-31 Impact factor: 9.298
Authors: Martin H Sørensen; Annemie S Bojer; Niklas R Jørgensen; David A Broadbent; Sven Plein; Per L Madsen; Peter Gæde Journal: Cardiovasc Diabetol Date: 2020-09-30 Impact factor: 9.951
Authors: Radzi M Noh; Alex J Graveling; Ninian N Lang; Audrey C White; Kuan K Lee; Nicholas L Mills; David E Newby; Chim C Lang; Brian M Frier Journal: Endocrinol Diabetes Metab Date: 2021-05-07